• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.类风湿关节炎患者肺栓塞和深静脉血栓形成的风险和趋势:一项基于普通人群的研究。
Rheumatology (Oxford). 2021 Jan 5;60(1):188-195. doi: 10.1093/rheumatology/keaa262.
2
Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study.痛风诊断前后静脉血栓栓塞风险趋势:一项基于普通人群的研究。
Rheumatology (Oxford). 2020 May 1;59(5):1099-1107. doi: 10.1093/rheumatology/kez398.
3
Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study.强直性脊柱炎患者的静脉血栓栓塞风险:一项基于普通人群的研究。
Ann Rheum Dis. 2019 Apr;78(4):480-485. doi: 10.1136/annrheumdis-2018-214388. Epub 2019 Feb 8.
4
Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.系统性硬化症患者发生肺栓塞和深静脉血栓形成的风险:一项基于普通人群的研究。
Arthritis Care Res (Hoboken). 2016 Feb;68(2):246-53. doi: 10.1002/acr.22673.
5
Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.多发性肌炎和皮肌炎患者发生深静脉血栓形成和肺栓塞的风险:一项基于人群的研究。
Ann Rheum Dis. 2016 Jan;75(1):110-6. doi: 10.1136/annrheumdis-2014-205800. Epub 2014 Sep 5.
6
The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.巨细胞动脉炎患者发生深静脉血栓形成和肺栓塞的风险:一项基于普通人群的研究。
Ann Rheum Dis. 2016 Jan;75(1):148-54. doi: 10.1136/annrheumdis-2014-205665. Epub 2014 Sep 29.
7
The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study.原发性干燥综合征患者深静脉血栓形成和肺栓塞的风险:一项基于普通人群的研究。
J Rheumatol. 2017 Aug;44(8):1184-1189. doi: 10.3899/jrheum.160185. Epub 2017 Mar 15.
8
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.类风湿性关节炎增加深静脉血栓和肺血栓栓塞症的风险:一项全国性队列研究。
Ann Rheum Dis. 2014 Oct;73(10):1774-80. doi: 10.1136/annrheumdis-2013-203380. Epub 2013 Aug 7.
9
Risk of venous thromboembolism in patients with rheumatoid arthritis.类风湿关节炎患者的静脉血栓栓塞风险。
Arthritis Care Res (Hoboken). 2013 Oct;65(10):1600-7. doi: 10.1002/acr.22039.
10
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.类风湿关节炎患者发生肺栓塞和深静脉血栓的风险:一项基于英国人群的门诊队列研究。
Ann Rheum Dis. 2013 Jul;72(7):1182-7. doi: 10.1136/annrheumdis-2012-201669. Epub 2012 Aug 28.

引用本文的文献

1
Catheter-Based Thrombectomy for Clot-In-Transit and Massive Pulmonary Embolism In A Young Patient with Rheumatoid Arthritis: Inflammation as A Hidden Catalyst for Catastrophic Thromboembolism.基于导管的血栓切除术治疗一名类风湿关节炎年轻患者的移行性血栓和大面积肺栓塞:炎症作为灾难性血栓栓塞的潜在催化剂
Eur J Case Rep Intern Med. 2025 Aug 18;12(9):005695. doi: 10.12890/2025_005695. eCollection 2025.
2
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.类风湿关节炎与血栓形成的炎症关联:致病分子机制及治疗方法
Curr Issues Mol Biol. 2025 Apr 18;47(4):291. doi: 10.3390/cimb47040291.
3
Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?Janus激酶抑制剂治疗炎症性疾病:静脉血栓栓塞风险是否过高?
Res Pract Thromb Haemost. 2024 Dec 31;9(1):102667. doi: 10.1016/j.rpth.2024.102667. eCollection 2025 Jan.
4
Rheumatoid arthritis, cardiometabolic comorbidities, and related conditions: need to take action.类风湿关节炎、心脏代谢合并症及相关病症:需采取行动。
Front Med (Lausanne). 2024 Jul 24;11:1421328. doi: 10.3389/fmed.2024.1421328. eCollection 2024.
5
A systematic review and meta-analysis of the association between the D-dimer and rheumatic diseases.D-二聚体与风湿性疾病关联的系统评价和荟萃分析。
Immun Inflamm Dis. 2024 Jul;12(7):e1349. doi: 10.1002/iid3.1349.
6
Clinical Characteristics and Prognosis of Acute Pulmonary Embolism with Hemoptysis in Autoimmune Disease Patients.自身免疫性疾病合并咯血的急性肺栓塞患者的临床特征和预后。
Int J Med Sci. 2024 May 19;21(8):1399-1407. doi: 10.7150/ijms.94052. eCollection 2024.
7
Machine-learning-based models assist the prediction of pulmonary embolism in autoimmune diseases: A retrospective, multicenter study.基于机器学习的模型辅助预测自身免疫性疾病中的肺栓塞:一项回顾性、多中心研究。
Chin Med J (Engl). 2024 Aug 5;137(15):1811-1822. doi: 10.1097/CM9.0000000000003025. Epub 2024 Jun 12.
8
Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism with JAK Inhibitors versus TNF Inhibitors in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.类风湿关节炎患者中使用JAK抑制剂与TNF抑制剂的主要不良心血管事件和静脉血栓栓塞风险:一项系统评价和荟萃分析
Mediterr J Rheumatol. 2024 Mar 30;35(Suppl 1):10-19. doi: 10.31138/mjr.171023.rof. eCollection 2024 Mar.
9
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE.在炎症和肺纤维化的双重作用下,结缔组织病相关间质性肺病(CTD-ILD)患者发生静脉血栓栓塞症(VTE)的易感性更高。
Thromb J. 2024 Apr 4;22(1):34. doi: 10.1186/s12959-024-00599-3.
10
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies.类风湿关节炎患者发生静脉血栓栓塞的风险:观察性研究的荟萃分析
BMC Rheumatol. 2024 Feb 2;8(1):5. doi: 10.1186/s41927-024-00376-9.

本文引用的文献

1
Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study.痛风诊断前后静脉血栓栓塞风险趋势:一项基于普通人群的研究。
Rheumatology (Oxford). 2020 May 1;59(5):1099-1107. doi: 10.1093/rheumatology/kez398.
2
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis.越来越多的证据表明 JAK 抑制剂在类风湿关节炎患者中的安全性。
Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i34-i42. doi: 10.1093/rheumatology/key287.
3
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?类风湿关节炎的 Janus 激酶(JAK)抑制剂相关血栓栓塞症:风险有多真实?
Drug Saf. 2018 Jul;41(7):645-653. doi: 10.1007/s40264-018-0651-5.
4
Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.患有银屑病关节炎、银屑病和类风湿关节炎患者的静脉血栓栓塞风险:一项基于普通人群的队列研究。
Eur Heart J. 2018 Oct 14;39(39):3608-3614. doi: 10.1093/eurheartj/ehx145.
5
Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.与普通人群相比,初发性类风湿关节炎患者5年死亡率有所改善——缩小了死亡率差距。
Ann Rheum Dis. 2017 Jun;76(6):1057-1063. doi: 10.1136/annrheumdis-2016-209562. Epub 2016 Dec 28.
6
The epidemiology of venous thromboembolism.静脉血栓栓塞症的流行病学
J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.
7
Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis.体重指数与类风湿关节炎风险:系统评价和剂量反应荟萃分析
Arthritis Res Ther. 2015 Mar 29;17(1):86. doi: 10.1186/s13075-015-0601-x.
8
The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.巨细胞动脉炎患者发生深静脉血栓形成和肺栓塞的风险:一项基于普通人群的研究。
Ann Rheum Dis. 2016 Jan;75(1):148-54. doi: 10.1136/annrheumdis-2014-205665. Epub 2014 Sep 29.
9
Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.多发性肌炎和皮肌炎患者发生深静脉血栓形成和肺栓塞的风险:一项基于人群的研究。
Ann Rheum Dis. 2016 Jan;75(1):110-6. doi: 10.1136/annrheumdis-2014-205800. Epub 2014 Sep 5.
10
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.类风湿性关节炎增加深静脉血栓和肺血栓栓塞症的风险:一项全国性队列研究。
Ann Rheum Dis. 2014 Oct;73(10):1774-80. doi: 10.1136/annrheumdis-2013-203380. Epub 2013 Aug 7.

类风湿关节炎患者肺栓塞和深静脉血栓形成的风险和趋势:一项基于普通人群的研究。

The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.

机构信息

Arthritis Research Canada, Richmond.

Experimental Medicine Program.

出版信息

Rheumatology (Oxford). 2021 Jan 5;60(1):188-195. doi: 10.1093/rheumatology/keaa262.

DOI:10.1093/rheumatology/keaa262
PMID:32617563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7785304/
Abstract

OBJECTIVES

To estimate the overall risk of venous thromboembolism (VTE), pulmonary embolism (PE) and deep vein thrombosis (DVT) among patients newly diagnosed with RA compared with the general population without RA; and to estimate the risk trends of VTE, PE and DVT after RA diagnosis up to 5 years compared with the general population.

METHODS

Using previously validated RA case definition, we conducted a matched cohort study using the population-based administrative health database from the province of British Columbia, Canada. We calculated incidence rates (IRs) and fully adjusted hazard ratios (HRs) for the risk of VTE, DVT and PE after RA index date.

RESULTS

Among 39 142 incident RA patients (66% female, mean age 60), 1432, 543 and 1068 developed VTE, PE and DVT, respectively. IRs for the RA cohort were 3.79, 1.43 and 2.82 per 1000 person-years vs 2.70, 1.03 and 1.94 per 1000 person-years for the non-RA cohort. After adjusting for VTE risk factors, the HRs (95% CI) were 1.28 (1.20, 1.36), 1.25 (1.13, 1.39) and 1.30 (1.21, 1.40) for VTE, PE and DVT, respectively. The fully adjusted HRs for VTE during the first five years after RA diagnosis were 1.60, 1.47, 1.40, 1.30 and 1.28, respectively. A similar trend was shown in PE.

CONCLUSION

This population-based study demonstrates that RA patients have an increased risk of VTE, PE and DVT after diagnosis compared with the general population. This risk is independent of traditional VTE risk factors and is highest during the first year after RA diagnosis, then progressively declined.

摘要

目的

评估新诊断为类风湿关节炎(RA)的患者与无 RA 的普通人群相比,静脉血栓栓塞症(VTE)、肺栓塞(PE)和深静脉血栓形成(DVT)的总体风险;并评估 RA 诊断后长达 5 年内 VTE、PE 和 DVT 的风险趋势与普通人群相比。

方法

我们使用先前验证过的 RA 病例定义,利用加拿大不列颠哥伦比亚省基于人群的行政健康数据库开展了一项匹配队列研究。我们计算了 RA 索引日期后 VTE、DVT 和 PE 的风险发生率(IR)和完全调整后的风险比(HR)。

结果

在 39142 例新发 RA 患者(66%为女性,平均年龄 60 岁)中,分别有 1432、543 和 1068 例患者发生了 VTE、PE 和 DVT。RA 队列的 IR 分别为每 1000 人年 3.79、1.43 和 2.82,而非 RA 队列的 IR 分别为每 1000 人年 2.70、1.03 和 1.94。在调整了 VTE 风险因素后,VTE、PE 和 DVT 的 HR(95%CI)分别为 1.28(1.20,1.36)、1.25(1.13,1.39)和 1.30(1.21,1.40)。RA 诊断后 5 年内 VTE 的完全调整 HR 分别为 1.60、1.47、1.40、1.30 和 1.28。PE 也呈现出类似的趋势。

结论

这项基于人群的研究表明,与普通人群相比,RA 患者在诊断后 VTE、PE 和 DVT 的风险增加。这种风险独立于传统的 VTE 风险因素,并且在 RA 诊断后的第一年最高,然后逐渐下降。